What causes male breast cancer? new study investigates
NCT ID NCT06219187
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study collected information from 93 men who have had breast cancer. Participants filled out a questionnaire about their life, work, family, and health history. The goal is to find patterns that might help explain why some men develop breast cancer. No treatments or drugs were tested.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify environmental or lifestyle factors that may increase the risk of male breast cancer.
- What could go wrong
- This is an observational study with no intervention, so it cannot prove cause and effect. The small sample size (93 participants) limits how widely the findings can be applied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
93 people
The number who actually took part.
- Started
-
Feb 2024
- Finished
-
Feb 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients with a history of male breast cancer (MBC) referenced in the IUCT-O's regional MutaFamily-MBC database.
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Male patient with a personal history of breast cancer 2. Age ≥ 18 years 3. Patient who has had an oncogenetic consultation at IUCT-O and is registered in the IUCT-O oncogenetic database 4. Patient for whom no pathogenic variant has been detected on the HBOC panel (HBOC-) 5. Patient with no objection to participation in the trial (for deceased patients: trusted support person with no objection to participation). Exclusion Criteria: 1\. Patient who has forfeited his/her freedom by administrative or legal award or who is under legal protection (curatorship and guardianship, protection of justice).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IUCT-O
Toulouse, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?